Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 390.3M shares as of Apr 29, 2026 (10-Q). Share count fell from 3.07B to 324.2M between Jul 30, 2025 and Oct 30, 2025, a pattern consistent with a reverse split (roughly 1-for-9); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Tranches exactly as the company dimensioned them in its 10-K filed Feb 24, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Balance-sheet fair value of warrants: $0 as of Dec 31, 2021.
Rough fully diluted estimate: 476.0M = 390.3M O/S + 85.8M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Registrations and offerings
S-3ASRApr 14, 2026fee exhibit found but no total offering amount (fees deferred, typical for automatic shelves)filing →
S-3ASROct 16, 2024fee exhibit found but no total offering amount (fees deferred, typical for automatic shelves)filing →
S-3Nov 7, 2023no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
Last 12 months: 4 executed · 1 registered.
EXECUTEDApr 29, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDApr 14, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.